3-((3aR,10aR)-2-Methyl-2,3,3a,4,10,10a-hexahydro-1H-2,4a-diaza-cyclopenta[b]fluoren-9-yl)-4-(1-methyl-1H-indol-3-yl)-pyrrole-2,5-dione hydrochloride

ID: ALA538718

Chembl Id: CHEMBL538718

PubChem CID: 45264052

Max Phase: Preclinical

Molecular Formula: C28H27ClN4O2

Molecular Weight: 450.54

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: Ro-32-0557 | CHEMBL538718|Ro-32-0557|SCHEMBL8323341

Canonical SMILES:  CN1C[C@@H]2Cn3c(c(C4=C(c5cn(C)c6ccccc56)C(=O)NC4=O)c4ccccc43)C[C@H]2C1.Cl

Standard InChI:  InChI=1S/C28H26N4O2.ClH/c1-30-12-16-11-23-24(19-8-4-6-10-22(19)32(23)14-17(16)13-30)26-25(27(33)29-28(26)34)20-15-31(2)21-9-5-3-7-18(20)21;/h3-10,15-17H,11-14H2,1-2H3,(H,29,33,34);1H/t16-,17+;/m0./s1

Standard InChI Key:  VAPUWJSPUKOQCG-MCJVGQIASA-N

Associated Targets(Human)

PRKD3 Tchem Protein kinase C (PKC) (1010 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRKACB Tchem cAMP-dependent protein kinase (PKA) (929 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PHKG2 Tchem Phosphorylase kinase (51 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Prkca Protein kinase C (PKC) (359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Prkca Protein kinase C alpha (23 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Prkcb Protein kinase C beta (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Prkcg Protein kinase C gamma (137 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Prkce Protein kinase C epsilon (2 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 450.54Molecular Weight (Monoisotopic): 450.2056AlogP: 3.43#Rotatable Bonds: 2
Polar Surface Area: 59.27Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 9.75CX Basic pKa: 8.61CX LogP: 2.93CX LogD: 1.89
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.48Np Likeness Score: 0.00

References

1. Davis PD, Hallam TJ, Harris W, Hill CH, Lawton G, Nixon JS, Smith JL, Vesey DR, Wilkinson SE.  (1994)  Bisindolylmaleimide inhibitors of protein kinase C. Further conformational restriction of a tertiary amine side chain.,  (11): [10.1016/S0960-894X(01)80349-8]
2. Davis PD, Hallam TJ, Harris W, Hill CH, Lawton G, Nixon JS, Smith JL, Vesey DR, Wilkinson SE.  (1994)  Bisindolylmaleimide inhibitors of protein kinase C. Further conformational restriction of a tertiary amine side chain.,  (11): [10.1016/S0960-894X(01)80349-8]

Source